infectious diseases

HIV and SIV Research Services

Preclinical HIV and SIV Research Services

At BIOQUAL, we have decades of experience delivering in vitro and in vivo preclinical research studies for human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV). 

 

We offer a wide range of relevant animal models and in vitro assays to support the development of novel vaccines and therapeutics, including simian-human immunodeficiency virus (SHIV) and humanized mouse models for HIV. 

 

Our highly experienced team and secure Biosafety Level 2 (BSL-2) containment facilities provide the highest safety standards for working with immunodeficiency viruses, and we are happy to develop custom models and assays to meet the needs of your research study. 

HIV and SIV Research Capabilities

BIOQUAL offers a full range of BSL-2 in vivo and in vitro preclinical research services to support the development of novel vaccines and therapeutics for HIV and SIV. Our services include:  

In Vivo HIV/SIV/SHIV Models

We offer a range of relevant in vivo models of HIV/SIV infection including humanized mouse models and non-human primates (NHPs), as well as SHIV hybrid virus models.  Our team draws on decades of hands-on experience to help you choose the right model for your research question or develop a new one if none exists. 

In Vitro HIV/SIV/SHIV Assays

We provide extensive laboratory services including viral stock generation, viral load testing, cytokine analysis, and flow cytometry and functional assays to characterize immune responses. We use our proven methodologies and scientific expertise to optimize existing assays and develop customized procedures, delivering accurate, consistent results that support robust decision-making along the preclinical journey. 

Integrated Preclinical Research Capabilities

By integrating in vitro laboratory services with small and large animal models, BIOQUAL supports preclinical research at every stage from the lab to the clinic, driving efficiency and ensuring regulatory compliance. Our clients benefit from expert advice, consistent methodologies, and high quality standards to advance therapeutic and vaccine candidates confidently toward clinical development.  

HIV and SIV Models

We offer a range of in vivo models for HIV and SIV, as well as SHIV hybrid models and custom model development.  

SHIV/SIV-infected NHPs serve as a model for HIV/AIDS pathogenesis in humans, enabling research into virus transmission and vaccine development as well as prevention and treatment regimens, while humanized mouse models are valuable for preclinical testing. 

HIV and SIV Assays

We offer a wide range of in vitro assays aimed at understanding viral- or vaccine-induced immune responses for HIV and SIV. 

Our standard preclinical assay services range from ELISA assays to detailed immune cell characterization. We are also happy to work with our clients to develop custom assays to support the development of novel vaccines and antivirals. 

Sample Processing

We receive and process HIV/SIV-infected samples safely and securely. 

Viral Load Testing

We offer qRT-PCR and TCID50 for HIV/SIV viral load testing. 

Immune Response Characterization

We offer flow cytometry characterization and functional assays of immune cell populations. 

Cytokine Analysis

We run cytokine detection and analysis assays using ELISpot, Luminex, and ELISA. 

Virus Stock Generation

We generate high-quality, well-characterized stocks of HIV in human peripheral blood mononuclear cells (PBMCs). 

HIV p24 ELISA Assay and Binding Antibody Monitoring

We offer p24 antigen ELISA assays to measure HIV capsid protein, and binding antibody ELISA assays to track the course of HIV/SIV infection and immune response. 

Integrated Preclinical Research Capabilities

At BIOQUAL, we know that innovative science needs solid support at every step of the journey from the lab to the clinic. Our preclinical research services range from early-stage in vitro assays and screening through to critical in vivo studies in a wide range of animal models, ensuring our partners have the robust, reliable data they need to advance groundbreaking vaccine and therapeutic research programs. 

Don’t see the model or assay you need? Talk to our scientists about our custom solutions.

Why Work With BIOQUAL

With more than four decades of experience, BIOQUAL is the expert preclinical CRO specializing in infectious disease and immunology. We are trusted by hundreds of clients across government, biopharma, and academic research institutes to deliver the quality, safety, and flexibility that they demand.  

Our highly experienced team and state-of-the-art Biosafety Level 3 facilities provide the highest safety standards for working with high-risk wild-type pathogens. And our AAALAC accreditation demonstrates our dedication to humane and compliant animal care, prioritizing welfare and establishing a reliable foundation for producing high-quality research data. 

Every preclinical research program comes with its own timeline, budget, and scientific challenges, so we work closely with our clients to develop tailored approaches that meet the specific needs of each study. We have the flexibility to adapt to changing demands and shifting priorities, and a proven track record of moving fast in response to rapidly emerging public health threats. 

HIV and SIV Research Publications

Testing a New HIV Vaccine

We carried out preclinical testing of a novel HIV vaccine in NHPs, aimed at generating broadly neutralizing antibodies.

Demonstrating the Effectiveness of Lenacapavir

We worked with Gilead to carry out a crucial in vivo study showing lenacapavir can protect against infection with SHIV, supporting subsequent clinical trials and regulatory approval for HIV pre-exposure prophylaxis (PrEP).

Discuss Your HIV Study

Get in touch to learn more about our preclinical research services and discuss your next HIV or SIV study.